AU2020359357A1 - Compositions and methods for extending lifespan - Google Patents

Compositions and methods for extending lifespan Download PDF

Info

Publication number
AU2020359357A1
AU2020359357A1 AU2020359357A AU2020359357A AU2020359357A1 AU 2020359357 A1 AU2020359357 A1 AU 2020359357A1 AU 2020359357 A AU2020359357 A AU 2020359357A AU 2020359357 A AU2020359357 A AU 2020359357A AU 2020359357 A1 AU2020359357 A1 AU 2020359357A1
Authority
AU
Australia
Prior art keywords
elegans
spp
animals
subject
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020359357A
Other languages
English (en)
Inventor
Priti H. Chatter
Jothi Amaranath Govindan
Elamparithi JAYAMANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marvelbiome Inc
Original Assignee
Marvelbiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marvelbiome Inc filed Critical Marvelbiome Inc
Publication of AU2020359357A1 publication Critical patent/AU2020359357A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/208—Fungi extracts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/02—Acetobacter
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2020359357A 2019-10-01 2020-09-23 Compositions and methods for extending lifespan Pending AU2020359357A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962909186P 2019-10-01 2019-10-01
US62/909,186 2019-10-01
PCT/US2020/052251 WO2021067100A1 (en) 2019-10-01 2020-09-23 Compositions and methods for extending lifespan

Publications (1)

Publication Number Publication Date
AU2020359357A1 true AU2020359357A1 (en) 2022-04-28

Family

ID=75337328

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020359357A Pending AU2020359357A1 (en) 2019-10-01 2020-09-23 Compositions and methods for extending lifespan

Country Status (9)

Country Link
US (1) US20220330597A1 (https=)
EP (1) EP4037697A4 (https=)
JP (2) JP7817925B2 (https=)
KR (1) KR20220073796A (https=)
CN (1) CN114555102A (https=)
AU (1) AU2020359357A1 (https=)
CA (1) CA3153779A1 (https=)
IL (2) IL291798B2 (https=)
WO (1) WO2021067100A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114365845B (zh) * 2022-02-18 2023-03-28 吉林大学 一种植物发酵组合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000861A2 (en) * 2001-06-22 2003-01-03 The Regents Of The University Of California Eukaryotic genes involved in adult lifespan regulation
JP2008214215A (ja) * 2007-03-01 2008-09-18 Mitsukan Group Honsha:Kk アポトーシス誘導能を有する組成物
WO2014102588A2 (en) * 2012-12-27 2014-07-03 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US20160051596A1 (en) * 2014-08-21 2016-02-25 Food Industry Research And Development Institute Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9867857B2 (en) * 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US10722543B2 (en) * 2016-01-28 2020-07-28 Oxyrase, Inc. Methods for inhibiting tumor growth using anaerobe microorganisms
JP2018131416A (ja) * 2017-02-16 2018-08-23 国立大学法人 鹿児島大学 免疫増強剤及びその製造方法
US11497235B2 (en) * 2017-09-04 2022-11-15 Kewpie Corporation Acetic bacterial cell-containing food composition and method of producing the same
CA3088782A1 (en) * 2018-01-23 2019-08-01 The General Hospital Corporation Compositions and methods for improving mitochondrial function
EP4028558A4 (en) * 2019-09-12 2024-01-03 MarvelBiome, Inc. Compositions and methods for characterizing a microbiome
KR20240113455A (ko) * 2021-09-17 2024-07-22 마블바이옴 인코포레이티드 신경퇴행성 질환을 치료하기 위한 마이크로바이옴 조성물, 성분 또는 대사산물의 방법 및 용도

Also Published As

Publication number Publication date
EP4037697A1 (en) 2022-08-10
CA3153779A1 (en) 2021-04-08
IL291798B2 (en) 2025-10-01
KR20220073796A (ko) 2022-06-03
CN114555102A (zh) 2022-05-27
IL320580A (en) 2025-07-01
JP2026021466A (ja) 2026-02-10
JP7817925B2 (ja) 2026-02-19
IL291798A (en) 2022-06-01
EP4037697A4 (en) 2024-04-03
WO2021067100A1 (en) 2021-04-08
IL291798B1 (en) 2025-06-01
JP2022551584A (ja) 2022-12-12
US20220330597A1 (en) 2022-10-20

Similar Documents

Publication Publication Date Title
Wu et al. Honey bee genetics shape the strain-level structure of gut microbiota in social transmission
US11284609B2 (en) Compositions and methods for characterizing a microbiome
Grompone et al. Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans
US11957723B2 (en) Methods and uses of microbiome compositions, components, or metabolites for treating neurodegenerative diseases
JP2023166397A (ja) 酸素感受性グラム陽性細菌の保護に使用されるポリペプチド
McKean et al. The costs of immunity and the evolution of immunological defense mechanisms
Bilbo et al. Bacterial infection early in life protects against stressor-induced depressive-like symptoms in adult rats
JP2026021466A (ja) 寿命を延長するための組成物及び方法
Heimesaat et al. Intestinal microbiota changes in mice lacking pituitary adenylate cyclase activating polypeptide (PACAP)—bifidobacteria make the difference
CN102858993B (zh) 筛选具有抗氧化作用的细菌的方法
Ye et al. Stevioside mitigates metabolic dysregulation in offspring induced by maternal high-fat diet: the role of gut microbiota-driven thermogenesis
RU2854523C1 (ru) Композиции и способы для увеличения продолжительности жизни
CN116847859A (zh) 微生物组组合物的方法和用途
HK40076210A (en) Compositions and methods for extending lifespan
Mir et al. Roles of progranulin and FRamides in neural versus non-neural tissues on dietary restriction-related longevity and proteostasis in C. elegans
Pei et al. Impaired colonic motility in high-glycemic diet-induced diabetic mice is associated with disrupted gut microbiota and neuromuscular function
CN121926964A (zh) 用于延长寿命的组合物和方法
Mhamed et al. Asthme et obésité: relation et implications thérapeutiques auprès des patients asthmatiques du Service de Pneumologie de Monastir, Tunisie
HK40076257A (en) Compositions and methods for characterizing a microbiome
Niosi et al. Kismet/CHD7/CHD8 affects gut biomechanics, the gut microbiome, and gut-brain axis in Drosophila melanogaster
Delprete Pathogenetic mechanisms of gastrointestinal symptoms in a mouse model of Fabry disease: insights on the microbiota-gut-brain axis
Nouar Using Caenorhabditis elegans as a model to investigate host-microbiome interactions in Parkinson’s disease
Sadegh Defining the Role of Inflammation and Effective Therapies for the Commonest Cause of Stroke in Children: Cerebral Cavernous Malformation (CCM)
Benian Indoles from commensal bacteria extend healthspan
von Frieling Effects of malnutrition on epithelia-microbe interactions in the intestinal tract of Drosophila melanogaster